Essity Aktiebolag B

  • TickerESSITY B
  • ISINSE0009922164
  • ExchangeNasdaq Nordic Stockholm
  • SectorPersonal Goods
  • CountrySweden

Essity AB: 2 directors sold

Two Directors at Essity AB sold 31,733 shares at between 31.100USD and 31.690USD. The significance rating of the trade was 94/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing Close periods where trading activity is restricted under listing rules. T...

Karl-Johan Bonnevier

Essity (Sell, TP: SEK290.00) - Facing increasing headwinds

Essity has benefited from strong earnings revision momentum for the last 18 months, but the positive trend appears broken, given the reversal of the easing raw material cost trends, more-challenging FX, and near-term risk to volumes, price/mix, and underabsorption of fixed costs. We find the shares in negative to neutral absolute and relative valuation territory, and have cut our EPS for 2020–2022e by 9–11%, prompting our downgrade to SELL (HOLD) with a target price of SEK290 (320).

Karl-Johan Bonnevier ...
  • Ole-Andreas Krohn
  • Olof Larshammar
  • Paul Harper

Northern Lights

Alexander Aukner ...
  • Håkon Astrup
  • Helene Kvilhaug Brøndbo
  • Jon Masdal
  • Karl-Johan Bonnevier
  • Martin Arnell
  • Martin Huseby Karlsen
  • Niklas Wetterling
  • Ole-Andreas Krohn
  • Patrik Ling
  • Rune Majlund Dahl
  • Simen Mortensen
  • Viktor Trollsten

Northern Lights

Karl-Johan Bonnevier

Essity (Hold, TP: SEK320.00) - Re-establishing its financial muscle

Essity’s Q1 results showed an impressive ability to meet Covid-19-related tissue demand, setting up record volume growth and a record price/mix to input cost benefit, something we expect to reverse into negative territory from Q3. Strong FCF and rapid deleveraging are opening new possibilities for 2021e, and we still view Essity as a relative safe haven. We also find the shares in neutral absolute and relative valuation territory, and therefore reiterate our HOLD and SEK320 target price.

Essity AB: 2 directors sold

Two Directors at Essity AB sold 31,733 shares at between 31.100USD and 31.690USD. The significance rating of the trade was 94/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing Close periods where trading activity is restricted under listing rules. T...

Karl-Johan Bonnevier

Essity (Sell, TP: SEK290.00) - Facing increasing headwinds

Essity has benefited from strong earnings revision momentum for the last 18 months, but the positive trend appears broken, given the reversal of the easing raw material cost trends, more-challenging FX, and near-term risk to volumes, price/mix, and underabsorption of fixed costs. We find the shares in negative to neutral absolute and relative valuation territory, and have cut our EPS for 2020–2022e by 9–11%, prompting our downgrade to SELL (HOLD) with a target price of SEK290 (320).

Karl-Johan Bonnevier

Essity (Hold, TP: SEK320.00) - Re-establishing its financial muscle

Essity’s Q1 results showed an impressive ability to meet Covid-19-related tissue demand, setting up record volume growth and a record price/mix to input cost benefit, something we expect to reverse into negative territory from Q3. Strong FCF and rapid deleveraging are opening new possibilities for 2021e, and we still view Essity as a relative safe haven. We also find the shares in neutral absolute and relative valuation territory, and therefore reiterate our HOLD and SEK320 target price.

Anders Idborg ...
  • André Thormann
  • Bengt Jonassen
  • Casper Blom
  • Erik Moberg
  • Fredrik Ivarsson
  • Johan Brown
  • Karl Bokvist
  • Mads Thinggaard
  • Magnus Andersson
  • Martin Melbye
  • Olof Cederholm
  • Peter Kurt Nielsen
  • Petter Nystrøm
  • Tobias Kaj

Talking Points - Axfood (Sell): An exaggerated rally

Columbus (Buy) Preview: Q1 hit was only in March Estimates up by 2% 2020e-2022e Downgrade to SELL on the back of recent rally

Martin Melbye ...
  • Øystein Elton Lodgaard

Essity - Boosted by (nec)Essity shopping

Strong Q1 as pre-announced, Q2 will likely be weaker Lower oil prices support margins - MTM EPS of SEK 18.4 Long-term outlook strong, valuation potential vs peers

Martin Melbye ...
  • Øystein Elton Lodgaard

Essity - Numbers and outlook as pre-announced

Clean EBITA as pre-announced – EPS was 5% below All-time high margin, strong org. growth, weaker in EM Outlook: lower Professional Hygiene sales in Q2

Karl-Johan Bonnevier ...
  • Ole-Andreas Krohn
  • Olof Larshammar
  • Paul Harper

Northern Lights

Alexander Aukner ...
  • Håkon Astrup
  • Helene Kvilhaug Brøndbo
  • Jon Masdal
  • Karl-Johan Bonnevier
  • Martin Arnell
  • Martin Huseby Karlsen
  • Niklas Wetterling
  • Ole-Andreas Krohn
  • Patrik Ling
  • Rune Majlund Dahl
  • Simen Mortensen
  • Viktor Trollsten

Northern Lights

Joachim Gunell ...
  • Karl-Johan Bonnevier
  • Martin Arnell
  • Niclas Gehin
  • Ole-Andreas Krohn
  • Rune Majlund Dahl

Northern Lights

Eivind Sars Veddeng ...
  • Joachim Gunell
  • Karl-Johan Bonnevier
  • Niclas Gehin
  • Ole Martin Westgaard
  • Ole-Andreas Krohn
  • Rune Majlund Dahl
  • Simen Mortensen

Northern Lights

Christer Magnergård ...
  • Håkon Astrup
  • Jimi Lehtonen
  • Jon Masdal
  • Karl-Johan Bonnevier
  • Martin Arnell
  • Martin Hoang Nguyen
  • Mattias Holmberg
  • Niclas Gehin
  • Nicolas McBeath
  • Niklas Wetterling
  • Ole Martin Westgaard
  • Ole-Andreas Krohn
  • Olof Larshammar
  • Rune Majlund Dahl
  • Simen Mortensen
  • Tomi Railo

Northern Lights

ESSITY AB sees an upgrade to Positive due to a better fundamental star rating

The general evaluation of ESSITY AB (SE), a company active in the Personal Products industry, has been upgraded by the independent financial analyst theScreener with the addition of a star. Its fundamental valuation now shows 4 out of 4 possible stars while its market behaviour can be considered as defensive. theScreener believes that the additional star(s) merits the upgrade of its general evaluation to Positive. As of the analysis date January 31, 2020, the closing price was SEK 306.00 and its potential was estimated at SEK 334.44.

Expert Corporate Governance Service (ECGS)

Essity – AGM 02 April 2020

In general, Essity is in compliance with the Swedish regulations relating to the organisation and procedures of the AGM.   Under ITEMS 12.1-12.10, the (re-)election of the board of directors is proposed.   In view of concerns over aggregate time commitments as well as some other concerns, ECGS recommends to vote OPPOSE to the (re-)election of: Mr. Pär Boman (ITEM 12.2), Ms. Annemarie Gardshol (ITEM 12.4) and Mr. Bert Nordberg (ITEM 12.6).   Under ITEM 13 the nomination committee proposes to re-appoint Mr. Pär Boman as Chairman of the board of directors. ECGS has various concerns over his...

Essity April 04th, 2019

In general, Essity is in compliance with the Swedish regulations relating to the organisation and procedures of the AGM. Under ITEMS 12.1-12.9, the (re-)election of the board of directors is proposed.In light of concerns over aggregate time commitments, ECGS recommends to vote OPPOSE to the (re-)election of: Mr. Pär Boman (ITEM 12.2) and Ms. Annemarie Gardshol (ITEM 12.4). Under ITEM 13, the nomination committee proposes to re-appoint Mr. Pär Boman as Chairman of the board of directors. As already mentioned above, ECGS has various concerns over his re-appointment and therefore does not suppo...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch